*Sign Up *Imprint *Contact
*Deutsche Version*English Version  
Site Search:
Not logged in. [Log in

Medical/biological Study (experimental study)

Chronic, low-level (1.0 W/kg) exposure of mice prone to mammary cancer to 2450 MHz microwaves. med./biol.

By: Frei MR, Jauchem JR, Dusch SJ, Merritt JH, Berger RE, Stedham MA
Published in: Radiat Res 1998; 150 (5): 568 - 576 ( open external web page PubMed Entry , open external web page Journal web site )

Aim of study (according to author)
To determine whether chronic, low-level exposure of mammary-tumor-prone mice to 2450 MHz radiofrequency radiation promotes an earlier onset (decreased latency), a greater total incidence, or a faster growth rate of mammary tumors.
Background/further details:
The current study was designed to replicate a previous study (publication 3413) but to increase the SAR from 0.3 W/kg to 1.0 W/kg to determine if a threshold SAR effect exists.

Endpoint

Exposure
General category: low level microwaves, 2.45 GHz

Field characteristicsParameters
2.45 GHz
continuous wave (CW)
exposure duration: repeated daily exposure, 20 h/day, for 78 weeks
power: 140 mW mean value (input power per waveguide)
SAR: 1 W/kg mean value (whole body)

FIELD View further expo parameters

Exposed system:
animal (species/strain): mouse/C3H/HeJ (possesses a milk-borne virus that induces mammary gland tumors)
whole body exposure

Methods
Endpoint/Measurement parameters/Methodology

investigated material: tissue slices (in vitro)
investigation on living organism
investigated organ systems: endocrine system, reproductive system, sense organs, immune system, muscular/skeletal system, cardiovascular system, respiratory system, autonomic nervous system, neuroendocrine system, CNS, viscera

time of investigation: during and after exposure

Main outcome of study (according to author)
The results indicate that under these experimental conditions, long-term, low-level exposure of mammary-tumor-prone mice to 2450 MHz radiofrequency did not affect mammary tumor incidence, latency to mammary tumor onset, mammary tumor growth rate, or survivorship when compared with sham-irradiated controls. Histopathological examination revealed no differences in numbers of malignant, metastatic, or benign neoplasms between the two groups.

(Study character: medical/biological study, experimental study, full/main study, replication/reproduction study)

Study funded by

  • Air Force, USA

Replication study of  iRelated articles i
Glossary: animal, autonomic nervous system, benign, biological, cancer, cardiovascular system, chronic, CNS, current, CW, endocrine system, endpoint, exposure, full/main study, GHz, growth, histopathological, immune system, incidence, in vitro, irradiated, latency, lesions, malignant, mammary gland, mammary tumor, mean value, metastatic, MHz, microwaves, morphological, muscular, neoplasms, neuroendocrine system, organism, palpation, power, radiation, radiofrequency, replication/reproduction study, reproductive system, respiratory system, SAR, sense organs, skeletal, species, strain, survival rate, threshold, tissue, tumor, virus, waveguide, whole body exposure

© 1997 - 2013, Research Center for Bioelectromagnetic Interaction (femu - RWTH Aachen University, Germany).

The informational contents of the EMF-Portal are available free of charge for personal and strictly non-commercial purposes. The informational contents of the EMF-Portal may be retrieved, read or printed, but not (i) copied, (ii) changed or (iii) saved in any format, neither electronically nor on other storage media. Permissions for publication, reproduction, commercial purposes or third party propagation of contents of the EMF-Portal – including partial excerpts or revised formats – have to be obtained from the femu Aachen University-copyright holders. By retrieving, reading or printing these documents you expressly state your agreement with all conditions in the fine print.

 Print view